Dengue Vaccine Development at the Dengue virus serotypes

Authors

  • Adinda Desi Irawati Magister Ilmu Farmasi
  • Hotimah Masdan Salim

DOI:

https://doi.org/10.33086/iimj.v1i1.1360

Keywords:

Dengue hemorrhagic fever (DHF), DENV, Vaccine

Abstract

Dengue hemorrhagic fever (DHF) is a disease caused by dengue virus (DENV1-4) and is transmitted by the Aedes aegypti mosquito. However, in 2015, official data from the member countries, WHO reported more than 3.2 million cases, including 10,200 severe dengue cases and 1181 deaths. The protein encoded by the genome of dengue virus. Major structural and non structural proteins making up the genome of dengue. From genomic data several studies found that mechanism of vaccine that can use in dengue virus. Several vaccines was establish in the world for example Live attenuated Vaccine, Chimera Vaccine, Subunit Vaccine, DNA vaccines DENV, Activated DENV Vaccine  - Whole Virus Particles, Activated  DENV Vaccine - Recombinant Subunit DENV, and DENV Vaccine 5.

Downloads

Download data is not yet available.

Published

2019-12-09

How to Cite

Desi Irawati, A., & Salim, H. M. (2019). Dengue Vaccine Development at the Dengue virus serotypes. International Islamic Medical Journal, 1(1), 9-15. https://doi.org/10.33086/iimj.v1i1.1360

Issue

Section

Articles